Department of Cardiology, Hospital do Espírito Santo de Évora, Évora, Portugal.
Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK.
Europace. 2022 Nov 22;24(11):1721-1729. doi: 10.1093/europace/euac088.
Recent technological advances have facilitated and diversified the options available for the diagnosis of cardiac arrhythmias. Ranging from simple resting or exercise electrocardiograms to more sophisticated and expensive smartphones and implantable cardiac monitors. These tests and devices may be used for varying periods of time depending on symptom frequency. The choice of the most appropriate heart rhythm test should be guided by clinical evaluation and optimized following accurate characterization of underlying symptoms, 'red flags', risk factors, and consideration of cost-effectiveness of the different tests. This review provides evidence-based guidance for assessing suspected arrhythmia in patients who present with symptoms or in the context of screening, such as atrial fibrillation or advanced conduction disturbances following transcatheter aortic valve implantation in high-risk groups. This is intended to help clinicians choose the most appropriate diagnostic tool to facilitate the management of patients with suspected arrhythmias.
近年来，技术的进步为心律失常的诊断提供了更多的选择和便利。从简单的静息或运动心电图，到更复杂和昂贵的智能手机和植入式心脏监测器。这些测试和设备的使用时间可能会根据症状的频率而有所不同。选择最合适的心律测试应该根据临床评估来指导，并在准确描述潜在症状、“警示信号”、风险因素以及考虑不同测试的成本效益后进行优化。本综述为评估有症状或在筛查背景下（如高危人群行经导管主动脉瓣植入术后的心房颤动或高级传导障碍）的疑似心律失常患者提供了基于证据的指导。这旨在帮助临床医生选择最合适的诊断工具，以方便管理疑似心律失常患者。
